Maria Isaac

Clinical Outcome Assessments: Conceptual Foundation—Report of the ISPOR Clinical Outcomes Assessment – Emerging Good Practices for Outcomes Research Task Force

Marc K. Walton, John H. Powers, Jeremy Hobart et al. · Value in Health · 2015 · 318 citations · Full text

Pharmacy, Clinical Sciences, Outcomes Research +13

Biomarkers of sarcopenia in clinical trials—recommendations from the International Working Group on Sarcopenia

Matteo Cesari, Roger A. Fielding, Marco Pahor et al. · Journal of Cachexia Sarcopenia and Muscle · 2012 · 293 citations · Full text

Medicine, Geriatric Medicine, Geriatrics +16

Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force

John H. Powers, Donald L. Patrick, Marc K. Walton et al. · Value in Health · 2017 · 180 citations · Full text

Pharmacy, Health Policy, Good Clinical Practice +13

Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease

Adam J. Schwarz, Maria Isaac, Luca Pani et al. · Alzheimer s & Dementia · 2014 · 94 citations · Full text

Medicine, Neurology, Neuroscience +17

The future is now: Model‐based clinical trial design for Alzheimer's disease

Klaus Romero, Kaori Ito, J. S. Rogers et al. · Clinical Pharmacology & Therapeutics · 2014 · 81 citations · Full text

Medicine, Pharmaceutical Policy, Pharmacology +17